Additionally, a distinctive aspect observed in cervical cancer models is that overexpression of GRP78 in cervical cancer (CVC) exhibits dual influences on cisplatin responsiveness, affecting both resistance and sensitization [113, 114]. Here, HSPA5 is linked to cervical carcinoma.